Market Cap

$581.5M

Volume

2.7M

Cash and Equivalents

$20.4M

EBITDA

-$61.9M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$27.7M

Profit Margin

21.00%

52 Week High

$3.90

52 Week Low

$0.50

Dividend

N/A

Price / Book Value

-17.19

Price / Earnings

-6.93

Price / Tangible Book Value

-17.19

Enterprise Value

$689.2M

Enterprise Value / EBITDA

-11.68

Operating Income

-$64.8M

Return on Equity

358.23%

Return on Assets

-18.45

Cash and Short Term Investments

$71.5M

Debt

$179.2M

Equity

-$33.8M

Revenue

$132.1M

Unlevered FCF

-$9.8M

Sector

Biotechnology

Category

N/A